<DOC>
	<DOC>NCT01083446</DOC>
	<brief_summary>This trial will study a possible effect of standard Israeli breakfast (30% of caloric value and 21 gram protein) on cognitive and executive functions (working memory, visual memory, concentration and coordination), on patients with mild-moderate liver cirrhosis.</brief_summary>
	<brief_title>A Nutritional Approach to Minimal Hepatic Encephalopathy</brief_title>
	<detailed_description />
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<criteria>All consented adults (age &gt; 18), with the diagnosis of CHILD A cirrhosis with MELD score of &lt; 10. Diagnosis of liver cirrhosis as documented by liver biopsy (stage IV) and / or fibroscan (score &gt; 12 kpa) and / or fibrotest (score &gt; 0.74) and /or imaging. History of &gt; grade II hepatic encephalopathy (HE). Diagnosis of dementia, Parkinson disease, Schizophrenia (Patients with major depression will be noted but not excluded). Use of sedatives, tranquilizers or anti psychotic medication during and/or 2 weeks prior to enrolling Use of antibiotics for any length of period during and/or 2 weeks prior to enrolling. Current use of lactulose or neomycin. Use of alcohol or elicit drugs during and/ or 6 months prior to enrolling.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Encephalopathy</keyword>
	<keyword>Cirrhotics</keyword>
</DOC>